Fundamental & Clinical Pharmacology

Fundamental & Clinical Pharmacology

基础与临床药理学

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Fundamental & Clinical Pharmacology》是由Wiley-Blackwell Publishing Ltd出版社于1987年创办的英文国际期刊(ISSN: 0767-3981,E-ISSN: 1472-8206),该期刊长期致力于药学领域的创新研究,主要研究方向为药学-医学。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0040...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比71.13%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在97篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Fundamental & Clinical Pharmacology审稿周期约为 较慢,6-12周 。该刊近年未被列入国际预警名单,年发文量约97篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 97 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 210 / 354

40.8%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 171 / 354

51.84%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:5.3 SJR:0.586 SNIP:0.738
学科类别 分区 排名 百分位
大类:Medicine 小类:Pharmacology (medical) Q2 95 / 272

65%

大类:Medicine 小类:Pharmacology Q2 144 / 313

54%

期刊发文

  • FTY-720 alleviates diabetes-induced liver injury by inhibiting oxidative stress and inflammation

    Author: Ye, Huijing; Sun, Mengyao; Jin, Zijie; Yuan, Yan; Weng, Hongbo

    Journal: FUNDAMENTAL & CLINICAL PHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1111/fcp.12897

  • Immunomodulatory effect of IL-35 gene-transfected mesenchymal stem cells on allergic asthma

    Author: Bao, Xiang-hua; Gao, Feng; Athari, Seyyed Shamsadin; Wang, Hongqun

    Journal: FUNDAMENTAL & CLINICAL PHARMACOLOGY. 2023; Vol. 37, Issue 1, pp. 116-124. DOI: 10.1111/fcp.12823

  • FKA-A NPs enhances PTX-A NPs efficacy to suppress ovarian cancer via regulating Skp2/YAP pathway

    Author: Li, Juan; Wang, Rongmei; Liu, Yongqing; Wu, Yuqian; Han, Leiqiang; Zheng, Lei; Bao, Zhengqiang

    Journal: FUNDAMENTAL & CLINICAL PHARMACOLOGY. 2023; Vol. 37, Issue 1, pp. 125-136. DOI: 10.1111/fcp.12828

  • Therapeutic targeting of DNA damage repair pathways guided by homologous recombination deficiency scoring in ovarian cancers

    Author: Lin, Chunxiu; Liu, Peng; Shi, Chaowen; Qiu, Lipeng; Shang, Dongsheng; Lu, Ziwen; Tu, Zhigang; Liu, Hanqing

    Journal: FUNDAMENTAL & CLINICAL PHARMACOLOGY. 2023; Vol. 37, Issue 2, pp. 194-214. DOI: 10.1111/fcp.12834

  • Afatinib triggers a Ni2+-resistant Ca2+ influx pathway in A549 non-small cell lung cancer cells

    Author: Tsai, Tien-Yao; Chen, Cing-Yu; Shiao, Lian-Ru; Ou, Ting-Tsz; Wu, Cheng-Hsun; Leung, Yuk-Man; Chow, Louis W. C.

    Journal: FUNDAMENTAL & CLINICAL PHARMACOLOGY. 2023; Vol. 37, Issue 2, pp. 253-262. DOI: 10.1111/fcp.12835

  • Effect of a high-fat meal on the relative bioavailability of HMPL-689 in Chinese healthy volunteers

    Author: Cao, Weie; Ding, Qichen; Wang, Yijun; Liu, Shuyun; Sun, Shixuan; Jiang, Fan; Xu, Xiaoyan; Sai, Yang; Wang, Jian; Chen, Qian; Liu, Yun

    Journal: FUNDAMENTAL & CLINICAL PHARMACOLOGY. 2023; Vol. 37, Issue 2, pp. 385-391. DOI: 10.1111/fcp.12843

  • MNK/eIF4E inhibition overcomes anlotinib resistance in non-small cell lung cancer

    Author: Zhang, Qi; Li, Hui; Li, Quan; Hu, Qiyan; Liu, Bo

    Journal: FUNDAMENTAL & CLINICAL PHARMACOLOGY. 2023; Vol. 37, Issue 2, pp. 245-252. DOI: 10.1111/fcp.12850

  • Survey the effect of drug treatment on modulation of cytokines gene expression in allergic rhinitis

    Author: Ma, Yan; Yang, Xiao-Hong; Tu, Yi; Athari, Seyyed Shamsadin

    Journal: FUNDAMENTAL & CLINICAL PHARMACOLOGY. 2023; Vol. 37, Issue 2, pp. 340-346. DOI: 10.1111/fcp.12847